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Article Synopsis 
Research has shown that modification of oral medicines is common in both primary care and long-
term care settings. However, this practice can alter drug safety and efficacy in vivo. This article 
describes a qualitative systematic review conducted to synthesise the available qualitative research 
on the knowledge, attitudes and beliefs of patients, healthcare professionals and patients about oral 
dosage form modification. Key factors influencing modification were elucidated. The synthesis 
highlights the need for increased engagement with and assessment of individual patient’s 
formulation requirements, which needs to be supplemented with evidence-based recommendation 
and multidisciplinary input into decision making.  
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Introduction 
Medication represents one of the most common and most important therapeutic interventions of 
modern medicine. However, key to optimising drug therapy is ensuring that the right patient 
receives the right drug at the right dose by the right route at the right time.
1
 Although oral dosage 
forms (ODF), such as tablets and capsules, are preferred by both healthcare professionals (HCPs) and 
patients, modifications may be necessary to facilitate administration of the right dose or to allow 
administration via the oral route. ODF modification can be defined as, “any alteration of an oral 
dosage form that can be performed at the point of administration”.
2
 These modifications are 
undertaken to facilitate medicine administration to patients with difficulty swallowing the intact 
dosage form (e.g. crushing tablets or opening capsules) or to facilitate fractional dosing 
(administration of part of an ODF to allow administration of a lower dose e.g. splitting tablets). 
Studies have shown that between 24.1% and 31.0% of all tablets prescribed for adult patients in 
primary care are split prior to administration,
3, 4
 with data from long term care  indicating  that 35.4% 
of older adults receive at least one split medication.
5
 ODF modifications to overcome swallowing 
difficulties are also prevalent, with up to one third of all occasions of medicine administration to 
older patients in long term care facilities involving ODF modification.
6
 Data from primary care 
suggest that between 9.0% and 37.4% of adult patients experience difficulty swallowing tablets and 
capsules, with the majority of those affected modifying the dosage form to overcome these 
difficulties.
7, 8
  
 
There are a number of safety and efficacy concerns around modified medicines such as reduced 
dose accuracy, reduced drug stability and the potential to affect the pharmacokinetic and 
pharmacodynamic profile of the drug in vivo. 
9-14
  Guidelines  advise that  modifications should only 
be undertaken as a “last resort” 
15
 when “other methods have been considered”.
16
 Additionally, there 
is growing concern amongst regulatory agencies about fractional dosing.
17, 18
 However, despite this, 
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evidence shows that ODF modifications are a routine part of clinical practice.
3, 19, 20
 While 
modifications may be necessary due to a lack of appropriate licensed formulations,
4, 5, 19
 it is clear 
from the literature that modifications occur even in situations where alternative formulations are 
available
3, 4, 21
  and / or in situations where the modification is expressly prohibited by the 
manufacturers guidelines.
3, 4, 20, 21
  
 
Whilst quantitative studies have provided useful evidence on the prevalence of ODF modifications 
and highlighted concerns, they have not elucidated the factors that influence the decision to modify. 
HCPs prescribe, dispense and administer modified ODF,
4, 22
 and patients modify medicines without 
the knowledge of their healthcare providers.
4, 22, 23
 These studies have shown that both HCPs and 
patients: have concerns about the appropriateness of modifications; experience difficulty when 
modifying medicines and; display significant knowledge deficits about ODF modification.
4, 20, 22, 24
 
Qualitative research methods can provide an insight into the knowledge, attitudes and beliefs of 
those who modify to gain a deeper understanding of the factors that influence behaviour and 
practice. Qualitative studies have been undertaken to investigate ODF modification, but to date, no 
systematic review of this literature has been conducted.   
 
Study Purpose 
The aim of this systematic review is to synthesize the available qualitative research on the 
knowledge, attitudes and beliefs of adult patients, healthcare professionals and carers about ODF 
modification. 
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Methods 
Details of the protocol for this systematic review were registered on PROSPERO and can be accessed 
at http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42015023494. 
 
Search strategy 
A systematic literature search of the following databases, from inception to September 2015, was 
undertaken: PubMed, Medline (EBSCO), EMBASE, CINAHL, PsycINFO, Web of Science, ProQuest 
Databases, Scopus, Turning Research Into Practice (TRIP), Cochrane Central Register of Controlled 
Trials (CENTRAL) and Cochrane Database of Systematic Reviews (CDSR). No language or time 
restrictions were placed on the initial search. A comprehensive search strategy was devised, using 
index and free-text terms, related to (i) patients, healthcare professionals or carers, (ii) medicine 
modification, (iii) knowledge and (iv) qualitative research. The search strategy was initially developed 
by the primary author (AMG) and subsequently approved by a qualified medical librarian prior to 
undertaking the searches. The reference lists of included studies were hand-searched to identify 
additional relevant studies. Citation tracking of included studies was also undertaken. A search for 
grey literature was completed; by searching the OpenGrey database, internet searching and using 
personal knowledge to identify further potentially relevant sources. The initial search was 
undertaken in September 2015 and an updated search was undertaken in June 2016. 
 
Study selection 
Titles were screened by one reviewer (AMG) to remove studies that did not meet the eligibility 
criteria. Each abstract was independently screened by two reviewers (AMG-full set and LJS or AMC). 
The full-text of articles identified as potentially eligible based on the abstract were obtained and 
assessed independently by two reviewers for inclusion (AMG and LJS or AMC) according to a priori 
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inclusion and exclusion criteria. In the case of any discrepancies between reviewers at any stage, a 
third reviewer independently examined the study and following discussion, a consensus on inclusion 
was reached by all three reviewers. 
 
Eligibility criteria 
Studies were eligible for inclusion if they met the following criteria: (i) used qualitative data 
collection and analysis methods; (ii) the full-text was available in English; (iii) included adult patients 
(18 years or more) who required ODF to be modified to meet their individual needs; (iv) included 
carers or HCPs (doctors, nurses, pharmacists, speech and language therapists) of patients who 
require ODF to be modified. For studies undertaken using mixed methods, only the qualitative 
component was included. Debate exists as to whether survey data is considered qualitative or 
quantitative, which has posed an issue in previous qualitative systematic reviews. 
25
 It was decided a 
priori that surveys would be excluded if the results were purely quantitative in nature, as this data 
lacks the necessary “conceptual depth and richness”,
26
 which is an approach that has been utilised 
previously. 
27
 Quantitative studies, systematic reviews, meta-analyses, meta-syntheses, editorials, 
commentaries, letters and conference abstracts were excluded. The primary outcomes of interest 
were patient, HCP and carer knowledge, attitudes and beliefs about the modification of ODF. 
 
Data extraction 
The data extraction form developed by the National Institute for Health and Care Excellence
28
  was 
modified by one reviewer (AMG) to meet the requirements of the systematic review. Data from the 
included studies were extracted by one reviewer (AMG). A second reviewer (AMC) independently 
verified the extracted data. Any disagreements were resolved by discussion and a consensus was 
reached by both reviewers.  
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Quality appraisal 
The quality of the included papers was independently assessed by two reviewers (LJS and AMG) 
using the Critical Appraisal Skills Programme (CASP) tool for Qualitative research.
29
 The CASP tool 
was chosen as it allows for assessment of the rigour, credibility and relevance of qualitative 
research.
30
 In the case of disagreements between reviewers regarding study quality, a third reviewer 
(AMC) independently assessed study quality and following discussion a consensus was reached by all 
three reviewers. There is debate about the value of undertaking a formal quality assessment for 
qualitative studies.
31
 Therefore, for this review, assessment of study quality was not used to guide 
inclusion or exclusion of studies but rather to moderate the findings of the review based on the 
quality of the studies contributing to the final analytical themes. 
 
Data Synthesis 
The thematic synthesis approach, as discussed by Thomas and Harden (2008),
32
 was used to 
synthesise the findings of the eligible studies. The thematic synthesis approach was chosen as it 
offers the advantage of “staying ‘close’ to the results of the primary studies, synthesising them in a 
transparent way, and facilitating the explicit production of new concepts and hypotheses”.
32
 Through 
this process, analytical themes are generated that offer new interpretations that “go beyond” the 
results of the primary studies.
33
 The thematic synthesis approach involves three stages: (i) free line-
by-line coding of the findings of the primary studies; (ii) organisation of “free codes” into descriptive 
themes; (iii) development of analytical themes.
32
  QSR International’s NVivo 10 Qualitative Data 
Analysis Software was used as an aid to the synthesis process.  Initial line-by-line coding of all text 
labelled “Results” or “Findings” in eligible studies was performed independently by two reviewers 
(LJS and AMG). The coded text was compared to check that coding was assigned correctly and 
consistently. The generation of the descriptive themes was undertaken by two reviewers (LJS and 
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AMG) during a group discussion. A third reviewer (AMC) independently examined and verified the 
descriptive themes generated and consensus was reached by all three reviewers.  Finally, the 
descriptive themes were used to generate analytical themes. Analytical themes were initially 
generated by two reviewers (AMG and LJS) independently, following this a number of group 
discussions were undertaken to consolidate the analytical themes identified.   
 
This systematic review is reported in accordance with the  Enhanced Transparency in Reporting the 
Synthesis of Qualitative Research (ENTREQ)  guidelines.
33
 
 
Results 
Study Selection 
In total, 6911 articles were identified from the database search. Following the removal of 1456 
duplicates, 5455 remained. Following the title screen, 5290 records were excluded. Of the 165 
articles that were examined for eligibility based on the abstract, 129 were excluded. The remaining 
36 full-text articles were reviewed to identify those that met the inclusion criteria for the review. 
During this stage, 31 articles were excluded. Two additional studies were identified through citation 
tracking of the included articles, no additional records were identified from hand-searching the 
reference lists. Therefore, seven articles were included in the systematic review. No additional 
eligible studies were identified in the updated search in June 2016. Figure 1 outlines the process of 
study selection. 
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Figure 1 Flow diagram of study selection process 
Records identified through database 
searching 
(n=6911) 
Records for title screen 
(n=5455) 
Records for abstract review 
(n=165) 
Full-text articles assessed for 
eligibility 
(n=36) 
Articles included in Systematic 
Review 
(n=7) 
1456 duplicates removed 
5290 records excluded based 
on title 
129 articles excluded based on 
abstract 
31 full-text articles excluded; 
Paediatric studies (n=2) 
Quantitative studies (n=8) 
Not available in English (n=2) 
Conference abstracts/ 
proceedings (n=6) 
Review article (n=1) 
Not related to medicine 
modification/ administration as 
defined for the review (n=12) 
 
Articles identified from citation 
tracking (n=2) 
Articles from reference lists 
(n=0) 
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Study Characteristics 
The characteristics of the included studies are summarised in Table 1. The views of HCPs were 
examined in three of the studies: one study included nurses,
34
 one included physicians
35
 and one 
included a mixed sample of HCPs.
36
 The remaining four studies investigated the views of patients.
37-
40
 All of the studies involving HCPs were directly related to the topic of this review.
34-36
 For the 
studies involving patients, one study directly addressed the topic of interest.
38
 Of the remaining 
three studies undertaken in patient cohorts, two investigated the problems experienced by patients 
in managing their medication
39, 40
 while one examined factors related to adherence.
37
 For these 
three articles, a number of the findings addressed the topic of interest and these findings were 
included in the synthesis for the review. Modifications to facilitate fractional dosing were discussed 
in three of the studies,
37, 39, 40
 while modifications for swallowing difficulties were the topic of 
consideration for four of the studies.
34-36, 38
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Table 1 Characteristics of included studies (listed alphabetically according to first author) 
Reference (Year) Location Participants (n) Method Analysis Aim Analytical Themes  
Barnes et al. 
(2006)
34
 
South 
Australia 
Registered 
Nurses 
(n=11)  
Semi-
structured 
interviews 
Thematic analysis 
broadly following 
Ekman and 
Segesten 
To explore issues concerning the 
nursing practice of altering medication 
dose forms prior to administration of 
medicines to residents in homes for 
older people 
Patient-centred individuality and 
variability 
Communication 
Knowledge and uncertainty 
Complexity 
Borgsteede et al. 
(2011)
37
 
The 
Netherlands 
Patients with 
type 2 diabetes 
mellitus (T2DM) 
(n=20) 
Semi-
structured 
interviews 
Content analysis 
and constant 
comparison 
To explore both factors related to high 
and lower levels of adherence that 
patients experienced in their 
medication use and to reflect upon 
the findings in the context of patient 
education and shared decision 
making. 
Patient-centred individuality and 
variability 
Knowledge and uncertainty 
Complexity 
Kelly et al. 
(2009)
36
 
United 
Kingdom 
HCPs including 
consultant 
physicians, 
nurses, 
pharmacists, 
dietitian, speech 
and language 
therapist and a 
senior lecturer in 
pharmacy 
practice 
(n=10) 
Focus group Content analysis 
using Colaizzi’s 
method 
To identify the problems experienced 
by a range of healthcare professionals 
related to administering medicines to 
patients with dysphagia and the 
solutions they use to overcome them 
Patient-centred individuality and 
variability 
Communication 
Knowledge and uncertainty 
Complexity 
Kelly et al. 
(2010)
38
 
United 
Kingdom 
Patients (n=11) Semi-
structured 
interviews 
Content analysis 
using Colaizzi’s 
method 
To understand the experiences of 
taking medication for older people 
with dysphagia 
Patient-centred individuality and 
variability 
Communication 
Knowledge and uncertainty 
Complexity 
Notenboom et al. The Patients aged Semi- Coded according To identify the practical problems that Patient-centred individuality and 
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(2014)
39
 Netherlands ≥70 years (n=59) structured 
interviews 
to a coding 
scheme; 
Framework type 
analysis 
older people experience with the daily 
use of their medicines and their 
management strategies to address 
these problems and to determine the 
potential clinical relevance of thereof 
variability 
Knowledge and uncertainty 
Complexity 
Pergolizzi Jr et al. 
(2014)
35
 
United 
States of 
America 
Physicians 
(n=34) 
Semi-
structured 
phone 
interviews 
Content analysis To understand the knowledge, 
attitudes, and practices of physicians 
and the beliefs/perceptions of 
patients regarding the treatment of 
chronic pain in the presence of 
dysphagia 
Patient-centred individuality and 
variability 
Communication 
Tordoff et al. 
(2010)
40
 
New 
Zealand 
Patients ≥65 
years (n=20) 
Semi-
structured 
interviews 
Grounded theory 
and constant 
comparison 
To explore how people 65 years and 
older in New Zealand manage their 
medicines in their own homes and the 
problems and concerns they might 
have with taking them 
Patient-centred individuality and 
variability 
Communication 
Knowledge and uncertainty 
Complexity 
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Quality Appraisal 
A summary of the results of the quality appraisal for the included studies is shown in Table 2. All of 
the studies provided a clear statement of the aims of the research, used qualitative methodology 
appropriately, and employed an appropriate research design and recruitment strategy. Three of the 
studies did not provide sufficient detail about data collection
35, 36, 39
, with two of the studies not 
discussing data saturation
35, 36
 and one not providing detail about the use of a topic guide.
39
 Four of 
the studies did not address reflexivity which relates to the researcher considering their role and 
potential bias.
34-36, 39
 Two of the studies did not provide sufficient detail about the data analysis 
process, particularly in relation to the number of researchers who performed the analysis.
35, 36
 
Finally, one study did not state whether ethical approval had been obtained, did not provide 
participant quotes to substantiate findings or discuss in detail the findings in light of existing 
evidence or the implications for practice.
35
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Table 2 Quality appraisal of included studies using the Critical Appraisal Skills Programme (CASP) Qualitative Research Checklist 
29
 
 Barnes et al. 
(2006)
34
 
Borgsteede et al. 
(2011)
37
 
Kelly et al. 
(2009)
36
 
Kelly et al. 
(2010)
38
 
Notenboom et 
al. (2014)
39
 
Pergolizzi Jr et al. 
(2014)
35
 
Tordoff et al. 
(2010)
40
 
Clearly stated 
aim(s)? 
√ √ √ √ √ √ √ 
Qualitative 
methodology 
appropriate? 
√ √ √ √ √ √ √ 
Appropriate 
research design? 
√ √ √ √ √ √ √ 
Appropriate 
recruitment 
strategy? 
√ √ √ √ √ √ √ 
Data collection? √ √ U √ U X √ 
Reflexivity? U √ U √ U X √ 
Ethical issues 
considered? 
√ √ √ √ √ X √ 
Rigorous data 
analysis? 
√ √ U √ √ X √ 
Clear statement 
of findings? 
√ √ √ √ √ U √ 
Value? √ √ √ √ √ √ √ 
Legend: √= Yes, X= No, U= Unclear
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Analytical Themes 
Four themes emerged from the synthesis: (i) patient-centred individuality and variability; (ii) 
communication; (iii) knowledge and uncertainty and (iv) complexity. 
Patient-Centred Individuality and Variability 
The central role of the patient and the importance of recognising the inherent inter- and intra-
patient variability emerged as a strong theme in all studies.
34-40
 Individuality is key, and variability of 
individual patient’s needs and requirements has an important role in ODF modification. Although 
Tordoff et al. (2010)
40
  reported that, “Most people had no difficulty swallowing tablets”, it was clear 
from all the studies that many patients experience difficulty with medication administration and 
modification. A number of factors contribute to this variability including: medical conditions,
34-36, 38
 
patient-related factors
34, 36-40
 and medication-related factors
34-40
 which can be further complicated by 
family and institutional influences on decision making.
34, 36
   
Many medical conditions can lead to dysphagia/ difficulty swallowing medicines thereby 
complicating medicine administration,
34-36, 38
 including; stroke,
34, 38
 cognitive 
impairment/dementia,
34, 36
 cancer ,
35
 Parkinson’s Disease
34, 36
 and epilepsy.
36
 However, the variable 
nature of these medical conditions further complicates ODF administration
36, 38
 as individual 
patients, despite having similar diagnoses, may have very different medication formulation 
requirements, “The first major theme is the broad spectrum of dysphagia… ‘There are three different 
categories of patient we’ve got here which give us problems with dysphagia’…… each variation of 
dysphagia brings its own problems in relation to medicine administration”.
36
 In addition, the  natural 
progression of these medical conditions means that a progressive decline in function is observed
35, 36, 
38
 or conversely, an improvement in swallowing capability can occur, “In the case of participants who 
were stroke survivors, swallowing could gradually improve”.
38
  Therefore, continuity of medication 
can be problematic with disease progression.
35, 36, 38
 It is clear that formulation choice and decisions 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
15 
 
regarding modification for individual patients are complicated by inherent variability; due to disease 
stage and severity.  
Individual patient-related factors were reported in all studies as being important regulators of how 
medicines are administered. These included; patient decision making for example choosing not to 
take medicines due to difficulty swallowing
34, 36-38
 or chewing medicines,
39, 40
 patient medication 
preferences such as wanting to continue previous administration practices
34, 38, 40
 or preferring to 
modify medicines despite intact swallow.
34, 38
 In addition, administration practices varied, not only 
from patient to patient, but also for an individual patient from administration-to-administration and 
from day-to-day
34, 38
 depending on additional factors including their mood at the time of 
administration, time of day and the number of medicines being administered. 
Medication related factors including the size,
34, 37-40
 texture,
38
 shape,
38
 taste,
34, 36, 38, 39
 number of 
medicines
34, 35, 37, 38
 and viscosity of oral liquids
36
 were reported by patients and HCPs as impacting on 
medication suitability and patient acceptability. However, the importance of medication 
characteristics varied from person to person,
34, 36, 38, 40
 “Small tablets were generally easier to 
swallow than large ones although one participant found small round ones the hardest to swallow. 
Three participants found large tablets difficult and two said that size and shape were irrelevant”.
38
 
Therefore, the preferred formulation characteristics vary from patient to patient, which is a crucial 
factor complicating medicine administration.  
The reasons that patients receive modified medicines may not be solely related to the individual 
patient’s needs, requirements or preferences. Family members influence on HCPs decision making 
was discussed in two studies.
34, 36
 This influence may result in HCPs making decisions based on family 
member’s priorities rather than patients’ preferences, “… [some] families tend to pill count and cost 
monitor and many of them prefer us to press on with the tablets and crush them rather than the 
[liquid] alternative which they prefer not to pay for … [t]here have been occasions where we’ve 
disregarded the resident’s request and favoured the family’s insistence in relation to the crushing of 
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medication.”.
34
 Institutional and professional issues were also discussed as important factors 
influencing medicine administration practices. Barnes et al. (2006)
34
 highlighted the pressure placed 
upon nurses to ensure prescribed medicines are administered, “All but one nurse presented the 
need to ensure that prescribed medications were administered as the dominant imperative”, along 
with the pressure to complete medicine administration in a timely manner, “Thus, the overall 
organizational requirements, including completion of the medication round, often took precedence 
over attending to individual needs of particular residents”.
34
  
Numerous options were discussed to overcome difficulties with formulations including changing the 
formulation for example to oral liquids,
34-36, 38
 discontinuing unnecessary medications,
36, 40
 using 
various coping strategies e.g. the chin-tuck position or using food or various liquids to facilitate 
intake
38-40
 or modifications.
34-40
 It was noted that alternative formulations were often not available
34, 
35
 or there was a lack of knowledge about the availability of alternatives.
34, 38
 However, even in 
situations where alternative formulations were available other problems arose including; cost 
34-36
; 
unsatisfactory formulation characteristics 
36
; and poor patient acceptability.
36, 38
 Therefore, these 
issues can result in alternatives not being fit for purpose and modifications of ODF are preferable or 
necessary. 
 
Communication 
The importance of communication was a recurring theme in the majority of included papers.
34-36, 38, 40
  
While communication plays an important role in the optimisation of medicine administration and 
modification practices, poor communication and lack of communication presents a significant barrier 
that may negatively influence medicine administration. Two distinct lines of communication were 
seen; communication between patients and their HCP and communication between HCPs. 
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Communication between patients and their healthcare professionals 
Communication between patients and their HCPs also influenced modification practices and the 
selection of appropriate alternatives that avoided the need for modification. In general, patients had 
a positive view of their HCPs.
36, 38
 However, there were examples of poor communication between 
patients and HCPs, which negatively impacted upon medication adherence;  “One man, finding it 
hard to break his aspirin tablets into quarters as prescribed, asked his GP to change them to the type 
he’d had in hospital. ‘I’ve told him but he don’t take any notice.’”.
40
 Good communication and 
continuity of care was important to patients, with locums unpopular as they are unfamiliar with the 
patient and their needs and preferences, “Key points were the need for GP continuity and the 
recognition that locums…are a drawback…So I thought, ‘Don’t call the locum!’”,
38
 “Variability of 
pharmacist was also identified as a problem, even when the patient went to the same pharmacy: 
‘Also, where we go it always seems to be a different pharmacist. You never see the same ones. There 
doesn’t seem to be a consistent one there’.
38
  
One of the barriers to effective communication seems to focus on the HCPs reactive, rather than 
proactive, approach to patient’s difficulties or preferences.
35, 36, 38
 This is compounded by the 
observation by Barnes et al. (2006),
34
 that individual patient’s medication formulation requirements 
are not routinely or systematically assessed. As a result, HCPs are unaware of patient’s requirements 
and make decisions about medicines for their patients without fully appreciating their needs. This 
was particularly true in the case of pharmacists with patients reporting that different formulations 
were dispensed without the patient’s views being sought, “Participant 3’s pharmacist had changed 
the formulation of one of his medicines from a smooth-coated, torpedo-shaped tablet to a chalky 
form that he found difficult to take, and he put the change down to the tablets being cheaper”.
38
 
However, communication should ideally be a two-way process and patients admitted that they often 
neglect to inform their HCPs about the difficulties they experience with medications.
36, 38
 This may be 
due to many reasons; (i) aphasia,
36
 (ii) carers collecting medicines,
38
 (iii) patient’s lack of knowledge 
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that alternative formulations may be available 
38
 or (iv) patients unwilling to question HCP 
decisions.
36, 38
  
Communication between healthcare professionals 
Extensive inter-professional communication, to discuss individual patient’s needs was reported in 
two studies,
34, 36
 “We speak to the pharmacist for him to have a look at what medications they’re on 
to see if those can actually be crushed before we actually give them crushed … [h]e (pharmacist) 
will… give us a suggestion as to what tablet, what alternatives we can use…and then we discuss it 
with the medical officer…”.
34
 However, this inter-professional communication often takes place on 
an informal basis rather than being a routine and systematic process, “Nurses were concerned that 
they were working in an information vacuum, due to limited information resources and informal 
communication with other healthcare professionals”.
34
 While on the whole communication and 
information sharing between healthcare professionals was noted as an aid to decision making, a key 
issue, highlighted by Kelly et al. (2009)
36
 centred on ‘data flow’, with necessary information not 
being available to the appropriate individual in a timely fashion. Data flow problems arise due to 
deficits in communication practices for example; prescriptions tend not to specify the necessary 
formulation or that a patient has dysphagia,
36
 and communication between specialists and primary 
care is problematic.
38
 The varying expertise of the different members of the multidisciplinary team 
further compound these communication deficits, “Even if medicine charts do contain information on 
dysphagia there are problems identifying a common language…Thus, as identified by the speech and 
language therapist: “We are not always sure what we should say..” ”.
36
 Therefore, the input of many 
different HCPs is often necessary to make the most appropriate decision, but the lack of a formal 
communication process hinders this. A formal, systematic process of communication between HCPs 
would ensure that all the necessary information is available for decision-making and would facilitate 
information and expertise sharing on a routine basis. 
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Knowledge and Uncertainty 
Knowledge about medicine modification and administration was an important theme that emerged 
from the synthesis. Although confidence in one’s knowledge and abilities was reported by one nurse, 
“...I rely on my own knowledge of medication, which has always been quite comprehensive because 
I’ve always dispensed medication and I’m quite experienced”,
34
 it was clear that overall there was a 
significant knowledge deficit and uncertainty about medicine modification and administration 
amongst both HCPs,
34, 36
 “… you’re participating in a practice that you’re really not totally au fait 
with” 
34
 and patients,
37, 38
 “One of the issues that participants identified was their own lack of 
knowledge”.
38
 This knowledge deficit arose due to a lack of information and guidance related to 
medicine modification, particularly for HCPs.
34, 36
 It was noted by Kelly et al. (2009) 
36
 that there is 
little formal guidance or information provided by the manufacturers and industry as modifications 
are generally unlicensed, “…absence of information because medicine formulations are frequently 
altered in order to administer them to dysphagic patients and so are given outside licence”.
36
 This 
was reiterated by Barnes et al. (2006)
34
 who highlighted the deficits of commonly used resources, 
“We have a series of medication resources, but not necessarily associated with the crushing of 
tablets, more associated with what the tablets are for”.
34
 
Consequently, the lack of explicit information resources results in a reliance on informal information 
provided by HCPs or continuation of previous medication modification and administration practices. 
For HCPs, seeking the advice and recommendations of other members of the multidisciplinary team 
was commonly undertaken,
34, 36
 “.. the nurses reported discussing individual resident’s medication 
needs with pharmacists and doctors”.
34
 However, although generally helpful, it was noted that 
different HCPs have different priorities with the result that nurses reported receiving conflicting 
advice which complicated decision making, “When the nurses sought advice about how to decide 
between the various options with which they were faced, they were sometimes given varying and 
contradictory advice. Different professional disciplines (nursing, medicine and pharmacy) that are 
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involved in the provision of residential care had conflicting views about what should be done”.
34
 
However, it is acknowledged that no one HCP has all the knowledge and expertise necessary to 
make an informed decision for individual patients, “… the knowledge related to dysphagia and 
medication that falls within each professional’s sphere of expertise”.
36
 Therefore, multidisciplinary 
team involvement is vital to ensure that all necessary expertise is available. HCPs also relied on their 
previous experience and practice to guide decision making, “Nurses tend to put their own 
interpretation on how things are done – governed by perhaps their social background in nursing, by 
their experience in nursing, by their academic experience in nursing”.
34
 The lack of a standard 
knowledge base, reliance on previous practice and varying interpretation of guidance, leads to 
varying and inconsistent practices.  
Patients were very reliant on information provided by HCPs,
37, 38
 “..you follow his [the doctor’s] 
advice.. The pharmacy provides those big information sheets, with everything written clearly. Well 
you read everything”.
37
 Therefore, HCPs have an important role in providing information, knowledge 
and skills to patients, formally through the provision of verbal and written instructions but also 
informally, through observation of HCP practice.
36, 38
 However, both HCPs
36
 and patients
38
 
acknowledged that inconsistent practice by HCPs led to patient confusion regarding best practice, “… 
each time a different nurse gave it [the medicine] they gave it in a different form… so how the patient 
was meant to learn which form they should do when they go home … it would very confusing I would 
imagine”.
36
 Similarly to HCPs, patients also relied on their previous experience and reported the use 
of various coping mechanisms to overcome difficulties with their medications including using food or 
warm fluids, the chin tuck position to facilitate swallowing and using tablet devices or learned 
techniques to facilitate fractional dosing.
37-40
  
Due to this knowledge deficit, patients and HCPs expressed concerns, fears and worries about 
modifying medicines, including concerns about the accuracy of fractional dosing,
37, 39
 the effect of 
the modification on the pharmacological action of the drug including absorption, the 
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pharmacokinetic profile and adverse effects.
34, 36, 38
 There were also concerns about the methods 
used to modify medicines including the potential for cross-contamination.
36
 Conversely, some HCPs 
expressed apprehension about not modifying medicines as this may lead to medicine 
discontinuation or choking.
34, 36
  
 
Complexity 
Complexity was a key theme that emerged from the synthesis. Although complexity was a factor 
associated with the themes discussed previously, the overall complexity associated with nearly every 
aspect of decision making for ODF modification ensured its importance as an analytical theme.  This 
complexity was particularly related to the need to balance the advantages and disadvantages 
associated with modification and the complexity of the healthcare structure. Medicine modification 
was seen to be both necessary and advantageous as it (i) facilitated administration of vital 
medicines,
34, 38
 (ii) promoted adherence
36, 38
 and (iii) overcame some of the concerns regarding 
choking
34
 or medicine discontinuation due to difficulty swallowing.
36
 It also facilitated the 
administration of the correct dose for individual patients.
39
 However, there was a conflict between 
these advantages and the accepted disadvantages of modification (including the lack of 
information,
34, 36
 difficulty modifying medicines,
37, 39, 40
 the unlicensed nature of  administration,
36
 the 
impact on nursing workload and time management,
34
 the taste of modified medicines
34, 36, 38
 and 
concerns around the efficacy and safety of modified medicines.
34, 36, 38, 39
 This conflict must be 
negotiated by HCPs and patients. Decision making is complicated by the observation by Kelly et al. 
(2009), “Although both problems and solutions were discussed by the group, they were not separate 
issues because a solution in one area could be a problem in another”
36
, which highlights the dilemma 
faced when trying to balance the conflicting aspects of medicine administration and modification. 
This leads to professional, therapeutic and ethical dilemmas.  
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This “complex” environment contributes significantly to the challenge of optimising ODF 
administration practices. Barnes et al. (2006)
34
 summed up the situation, “This complex and ‘messy’ 
environment meant that the implementation and evaluation of the process of alteration of 
medications, rather than being systematic and orderly, was often ad hoc”. This complexity arises due 
to a number of inter-related factors; the lack of a systematic, proactive assessment of patient’s 
needs, the absence of clear, explicit evidence based guidance for staff and patients, the informal 
communication structures and the hierarchical structure of the healthcare system.    
 
Discussion 
This systematic review synthesised the available qualitative research evidence on the knowledge, 
attitudes and beliefs of patients and HCPs about the modification of oral dosage forms. Key 
challenges include; the variability of individual patient’s requirements, poor communication 
practices and lack of knowledge which when combined with the multi-faceted healthcare 
environment complicate decision making regarding ODF modification and administration. Although 
there were a limited number of eligible studies, particularly involving patients, the strength of this 
review lies in the fact that the synthesis included studies investigating the perspectives of both HCPs 
and patients. This provides a deeper understanding of the challenges encountered from prescribing 
right through to medication-taking behaviour. In addition, the diverse nature of patients in the 
included studies is a strength of the systematic review as it highlights the range of experiences 
encountered. The similarity of findings between studies adds to the validity of the findings and 
highlights key areas that need to be addressed. However, it also served to elucidate differences in 
the knowledge, beliefs and priorities of patients and HCPs which may give rise to misunderstandings 
and conflict in practice.  
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This review highlights that ODF selection for patients is complicated by the variable nature of 
patient’s needs and preferences, which is influenced by the interplay between patient’s medical 
conditions, patient’s preferences, formulation characteristics as well as external influences including 
family input. Whilst it is widely accepted and recommended that healthcare providers treat the 
patient as an individual and “for services to be tailored to respond to the needs, preferences and 
values of the patient”,
41
 the continual move towards clinical guidelines, protocols and treatment 
algorithms has raised concerns about the standardization of medical care at the expense of 
individualised patient-centred care.
42
 While there are on-going efforts to ensure that patient’s 
preferences are considered in the implementation of evidence based guidelines, it is clear from this 
synthesis that variability of patient disease state and preference is a major factor that must be 
considered when choosing appropriate formulations. Therefore, communication, between patients 
and healthcare professionals and between different HCPs, is vital. This review has also illustrated 
however that poor communication between patients and their HCPs is widespread and results in 
poor awareness of patient’s needs. This finding is consistent with previous studies which report that 
patients do not discuss their difficulties with medication with their HCP and HCPs do not routinely 
enquire about these difficulties.
8, 23
 There is a clear need for the routine evaluation of patient’s ODF 
requirements prior to the prescribing, dispensing and administration of medication. A previous 
quantitative systematic review called for the development and routine use of a validated screening 
tool to identify patients with difficulty swallowing medication.
6
 Use of such a tool may help to 
overcome the current communication deficit and informal, ad-hoc assessment process. 
Communication between members of the multidisciplinary team, particularly at transitions of care 
was also shown to be suboptimal which is in-line with previous literature.
43
  Continuity of healthcare 
at transitions of care is a major challenge facing the healthcare system.
44
 Again, a formal, systematic 
process of communication may help to address this, as structured communication has been shown 
to improve the effectiveness of information transfer and communication between HCPs.
45
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In order to make appropriate decisions for individual patients, HCPs require timely access to 
evidence based information. A clear issue that emerged from the synthesis is the lack of information 
about the appropriateness of ODF modifications which created a knowledge deficit and subsequent 
concern amongst HCPs. Given that patients rely on their HCPs to provide advice about medication 
use, this invariably results in a lack of knowledge amongst patients about ODF modification. Previous 
research has shown an absence of explicit information to support clinician decision-making 
regarding modifications.
3, 19
 The absence of accurate, evidence-based information contributes to the 
concerns of patients and HCPs and the complexity of decision making. Improved education regarding 
ODF modification may be one method of improving knowledge, however, this needs to be 
supplemented by increased availability of information about the potential consequences of 
modification of medicines. 
This review has highlighted the complexity associated with ODF modification and the challenges of 
optimising ODF administration. Interventions to reduce inappropriate tablet splitting, have focused 
on the prescriber and utilised a computerised decision support and warning system.
46, 47
 Both studies 
reported that the computerised system reduced the frequency of inappropriate splitting, with Hsu et 
al. (2014)
47
 reporting a substantial effect on prescribing behaviour. However, Quinzler et al. (2009)
46
 
reported that half of all alerts were not acted on by the physician despite a more suitable 
formulation being available in 82% of cases. Bourdenet et al. (2015)
48
 investigated if practice 
recommendations on crushing tablets could lead to an improvement in crushing practices. Following 
the implementation of these recommendations, significant reductions in medicine crushing and 
inappropriate crushing were seen. A study by Hanssens et al. (2006)
49
 found that a two day training 
program improved nurses knowledge about medicine administration for patients with swallowing 
problems and feeding tubes, however, the impact of this improvement in knowledge on practice was 
not assessed. The results of this synthesis suggest that a complex, multi-faceted intervention will be 
required to optimise ODF modification practices and future interventions should be cognisant of the 
findings of this review. Any intervention or quality improvement initiative must consider all the 
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factors and challenges encountered by patients and HCPs in daily practice. This review has served to 
highlight some of the prominent influencing factors. A gap in the literature is the absence of 
qualitative research investigating carer’s perceptions of ODF modification. Further research 
investigating the views of HCPs and patients is also necessary given the limited evidence available. In 
particular, given the observation that many patients without any clinical evidence of dysphagia are 
modifying ODF without the knowledge of their healthcare professional, further research directly 
focusing on ODF modification from the perspective of patients is required. Only one such study has 
been reported to date. 
The results of the synthesis suggest that to optimise ODF modification and administration practices, 
input is needed from patients and all members of the multidisciplinary team. The needs of patients 
should be routinely and systematically assessed when medications are prescribed and dispensed. 
Decision-making should take into consideration the individual needs of the patient but reliable and 
pertinent information from drug manufacturers, guidelines and recommendations from healthcare 
colleagues are needed to support this.  
There were a number of limitations associated with this review. For three of the studies involving 
patients the review topic was not the sole focus of the studies, therefore, not all the findings were 
relevant for inclusion in the synthesis. The inclusion of English language articles only, may hinder the 
generalizability of the findings.  
 
Conclusion 
Through synthesis of the existing qualitative literature, the findings of this systematic review have 
highlighted that key factors influencing the knowledge, attitudes and beliefs of patients and their 
healthcare professionals about oral dosage form modifications are patient-centred individuality and 
variability, communication, knowledge and uncertainty, and complexity. These factors can act as 
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both barriers and facilitators to medicine administration and modification. It is evident from the 
synthesis that the individual needs of patients should be routinely and systematically assessed and 
that decision-making should be based on evidence based recommendations with multidisciplinary 
input. Further research is needed to optimise ODF modification practices and the findings of this 
synthesis should inform the development of future interventions. 
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